STVN vs MMSI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
STVN · Stevanato Group$13.57 ▲ 2.73%
MMSI · Merit Medical Systems$87.23 ▼ 2.67%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- STVN -43.8%
- MMSI -1.2%
Head to head
| Metric | STVN | MMSI |
|---|---|---|
| Price | $13.57 | $87.23 |
| Change today | ▲ 2.73% | ▼ 2.67% |
| Market cap | $3.71B | $5.23B |
| Return, 3 months | -34.1% | -2.8% |
| Return, year to date | -32.3% | -1.0% |
| Return, 1 year | -43.5% | -0.4% |
| P/E (TTM) | 23.7 | 32.7 |
| P/B | 2.1 | 3.0 |
| P/E percentile vs own 5y | 43rd | 6th |
| Dividend yield | 0.45% | – |
| Revenue growth (YoY, latest qtr) | +7.8% | +8.4% |
| Net profit growth (YoY) | -22.7% | +52.4% |
| Gross margin | 29.2% | 49.4% |
| Operating margin | 17.4% | 13.5% |
| Net margin | 11.0% | 9.9% |
| Return on equity | 9.1% | 9.8% |
| Analyst target vs. price | +71.3% | +27.4% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 23 | 46 |
| 30-day volatility | 102.2% | 40.6% |
| Max drawdown, 1 year | -49.0% | -35.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MMSI is the largest of the group by market value.
- MMSI has returned the most over the past year.
- STVN carries the lowest trailing P/E.
- MMSI is growing revenue fastest.
- STVN keeps the most profit per dollar of sales.
- MMSI has been the calmest stock over the last 30 days.